- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06786364
Types of Photoplethysmographic Waves in Adult Patients with Septic Shock (SHOCK PLETH)
January 15, 2025 updated by: Juan Fernando Bautista Garcia, Hospital General de México Dr. Eduardo Liceaga
The objective of this study is to identify the types of Photoplethysmographic waves present in adults with septic shock and determine whether these waves correlate with other variables of tissue hypoperfusion such as capillary refil, serum lactate and mottling score.
Study Overview
Status
Recruiting
Conditions
Detailed Description
Photoplethysmography is the technology used in pulse oximeters in order to calculate arterial oxygen saturation and pulse rate, this technology generates a wave whose morphology has been related to blood flow and arterial tone.
Recently Tusman and collaborators described a morphological classification of the photoplethysmografic wave that has a high correlation with arterial tone, such classification is divided in 6 types; Types I and II indicate vasoconstriction, Type III normal arterial tone and Types IV, V and VI describe mild, medium and severe vasodilation respectively, therefore it could be used to identify the arterial tone in those patients with septic shock.
This study will identify the type of photoplethysmographic waves that are present in adults with septic shock based in the Tusman and collaborators classification, it will also describe the frequency of appearance and their correlation with other hemodynamic variables such as capillary refill, serum lactate, mottling score, heart rate, mean arterial pressure, pulse pressure and perfusion index.
Study Type
Observational
Enrollment (Estimated)
116
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Juan Fernando Bautista Garcia, MD
- Phone Number: 5573855591
- Email: jbtagarcia@gmail.com
Study Locations
-
-
Cuauhtemoc
-
Mexico city, Cuauhtemoc, Mexico, 06726
- Recruiting
- Hospital General de México Dr. Eduardo Liceaga
-
Contact:
- Hospital General de México Dr. Eduardo Liceaga Hospital General de México Dr. Eduardo Liceaga, Hospital
- Phone Number: 1316 5527892000
- Email: direccionhgmliceaga@gmail.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
All adult patients admitted to the emergency department at "Hospital General de México Dr. Eduardo Liceaga" and meet the criteria for septic shock established in Sepsis 3.0 and have signed the informed consentment will be included in the study.
Description
Inclusion Criteria:
- Adult patients of 18 years of age and above dignossed with septic shock according to the definition stated in Sepsis 3.0
- Patients with axillary temperature above 36°C
- Patients and/or family that agree to participate in such study and sign the informed consentment
- Patients that tolerate supine position
Exclusion Criteria:
- Patients with Cardiogenic shock, hipovolemic, obstructive and distributive (neurogenic, anafilactic) shock the exception being septic shock
- Patients with history of any type of cardiac arrhythmia
- Patients with history of chronic hepatic disease
- Patients with limited or diffuse systemic sclerosis
- Patients that have scarring, nail polish or thickened nails that may impede the proper placement and accurate measurement of photoplethysmography with the pulse oximeter
- Patients with history of heart insufficiency P- atients with septic shock that already have vasopressor aggents
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Photoplethysmography wave types in adult patiens with septic shock
Time Frame: After the inclusion of the patient.
|
The type of Photoplethysmography wave obtained and digitized through the sensor of a conventional pulse oximeter without autoscale.
The wave will be classified in type I, II, III, IV, V and VI according to the criteria proposed by Tusman and collaborators
|
After the inclusion of the patient.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Capillary refill
Time Frame: After the inclusion of the patient
|
Mesurement of the time it takes for the ventral surface of the fingers to return to its normal color after being compressed by a transparent microscope slide for 10 seconds.
Measured in seconds.
|
After the inclusion of the patient
|
|
Mottling score
Time Frame: After the inclusion of the patient
|
Classification regarding the type of mottling surrounding the knee in each patient.
The classification is as folllows 0= no mottling, 1= Mottling the size of a coin on the knee, 2= mottling extending just over the superior part of the knee, 3= Mottling covering up to half the thigh, 4= mottling continues to the inguinal fold, 5= severe mottling extending beyond the inguinal area.
|
After the inclusion of the patient
|
|
Serum lactate levels
Time Frame: After the inclusion of the patient
|
Mesurement of serum lactate through venous blood gass analysis at hospital admittanace.
Mesured in mmol/L
|
After the inclusion of the patient
|
|
Heart rate
Time Frame: After the inclusion of the patient
|
Determination of the number of heart beats per minute in patients obtenined with telemetry.
Messured in beats per minute
|
After the inclusion of the patient
|
|
Sistolic and diastolic blood pressure
Time Frame: After the inclusion of the patient
|
Messurement of arterial blood pressure with an adult sized aneroid sphygmomanometer.
Messurement in mmHg.
|
After the inclusion of the patient
|
|
Perfussion index
Time Frame: After the inclusion of the patien
|
Messurement of the perfusion index obtained and calculated by a sensor in a conventional pulse oximeter without autoscale.
Measurement in whole numbers.
|
After the inclusion of the patien
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Juan Fernando Bautista Garcia, MD, Hospital General de México Dr. Eduardo Liceaga
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 1, 2024
Primary Completion (Estimated)
May 1, 2025
Study Completion (Estimated)
May 30, 2025
Study Registration Dates
First Submitted
January 15, 2025
First Submitted That Met QC Criteria
January 15, 2025
First Posted (Actual)
March 25, 2025
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
January 15, 2025
Last Verified
January 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- DI/24/401/03/33
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Photoplethysmography
-
Hospital Privado de Comunidad de Mar del PlataRecruitingMicrocirculation | PhotoplethysmographyArgentina
-
Singapore General HospitalNervotec Pte. Ltd.RecruitingRemote Photoplethysmography , Blood PressureSingapore
-
Fondation LenvalRecruitingUsing Remote Photoplethysmography for Physiological ParametersFrance
-
Central Hospital, Nancy, FranceRecruitingPlethysmography | Remote Photoplethysmography Imaging | Physiological ParametersFrance
-
The University of Hong KongPanopticAIRecruitingVital Signs | PhotoplethysmographyHong Kong
-
Seerlinq s. r. o.Premedix AcademyCompletedHeart Failure | Right Heart Catheterization | PhotoplethysmographySlovakia
-
SEFA HAKTAN HATIKEnrolling by invitationTranscutaneous Electric Nerve Stimulation | Photoplethysmography | Heart Rate Variability (HRV) | Blood Pressure Monitoring | Autonomic Nervous System (ANS) Functioning and Mood StateTurkey (Türkiye)
-
Universidad de LeónCompletedVenous Stasis | Foot | Foot Orthoses | PhotoplethysmographyPortugal